We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$373M
(+5.3%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
62.33%
Holding
1,161
New
145
Increased
742
Reduced
165
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$55.7M |
| 2 |
iShares Gold Trust
IAU
|
+$31.5M |
| 3 |
Hyatt Hotels
H
|
+$22.1M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$18M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$20.2M |
| 2 |
Celldex Therapeutics
CLDX
|
+$15.3M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.52M |
| 4 |
Palantir
PLTR
|
+$4.79M |
| 5 |
RTX Corp
RTX
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.28% |
| 2 | Consumer Discretionary | 6.79% |
| 3 | Healthcare | 3.4% |
| 4 | Financials | 3.36% |
| 5 | Communication Services | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CME Group
CME
$94.8B
| $1.8M | 0.02% |
9,328
| – | – |
|
252
Royal Caribbean
RCL
$85.6B
| $1.79M | 0.02% |
20,169
+509
| +3% | +$41.2K |
|
|
FITB
253
Fifth Third Bancorp
FITB
$51.8B
| $1.79M | 0.02% |
41,888
+897
| +2% | +$34.4K |
|
254
Booking.com
BKNG
$161B
| $1.77M | 0.02% |
18,650
+1,375
| +8% | +$123K |
|
255
GE Aerospace
GE
$384B
| $1.72M | 0.02% |
26,802
-4,129
| -13% | -$265K |
|
256
Pacific Biosciences
PACB
$370M
| $1.72M | 0.02% |
67,107
+250
| +0.4% | +$7.41K |
|
257
Edwards Lifesciences
EW
$51.7B
| $1.71M | 0.02% |
15,109
+539
| +4% | +$61.5K |
|
258
A.O. Smith
AOS
$8.7B
| $1.7M | 0.02% |
27,899
+9,453
| +51% | +$660K |
|
|
EA
259
DELISTED
Electronic Arts
EA
| $1.7M | 0.02% |
11,985
-163
| -1% | -$22.9K |
|
260
Prologis
PLD
$133B
| $1.69M | 0.02% |
13,442
+2,224
| +20% | +$289K |
|
|
MRSH
261
Marsh
MRSH
$91.5B
| $1.66M | 0.02% |
10,988
+989
| +10% | +$150K |
|
262
AstraZeneca
AZN
$250B
| $1.66M | 0.02% |
13,808
+7,657
| +124% | +$891K |
|
263
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $1.65M | 0.02% |
27,995
+9
| +0% | +$551 |
|
264
Expeditors International
EXPD
$23.2B
| $1.64M | 0.02% |
13,737
+6,457
| +89% | +$808K |
|
265
General Motors
GM
$76.8B
| $1.64M | 0.02% |
31,017
+10
| +0% | +$531 |
|
266
Nucor
NUE
$62.1B
| $1.63M | 0.02% |
16,447
-4,450
| -21% | -$473K |
|
267
TJX Companies
TJX
$178B
| $1.62M | 0.02% |
24,539
+2,469
| +11% | +$172K |
|
268
BlackRock Income Trust
BKT
$341M
| $1.61M | 0.02% |
88,121
| – | – |
|
269
ConocoPhillips
COP
$141B
| $1.61M | 0.02% |
23,803
+11,552
| +94% | +$667K |
|
270
American Electric Power
AEP
$68.4B
| $1.61M | 0.02% |
19,784
+689
| +4% | +$60.1K |
|
271
Dow Inc
DOW
$21.2B
| $1.61M | 0.02% |
27,908
+3,237
| +13% | +$198K |
|
272
Charter Communications
CHTR
$18.2B
| $1.6M | 0.02% |
2,197
+198
| +10% | +$150K |
|
273
PACCAR
PCAR
$70.1B
| $1.59M | 0.02% |
30,251
-66
| -0.2% | -$3.66K |
|
274
Aflac
AFL
$62.6B
| $1.59M | 0.02% |
30,481
+3,769
| +14% | +$206K |
|
275
Ares Management
ARES
$30.9B
| $1.59M | 0.02% |
21,478
+7,652
| +55% | +$551K |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cresset Asset Management held 1,161 positions worth $7.43B, up 5.3% from $7.06B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Cresset Asset Management deployed $381M of net new capital in Q3 2021, opening 145 new positions and adding to 742 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $20.2M trimmed.
- Cresset Asset Management's largest Q3 2021 buy was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
- Cresset Asset Management added most to ARK Innovation ETF in Q3 2021, an estimated $55.7M increase.
- Cresset Asset Management's biggest Q3 2021 reduction was Apple, cutting an estimated $20.2M.
- Cresset Asset Management fully exited Celldex Therapeutics in Q3 2021, selling an estimated $15.3M.
- Cresset Asset Management's ten largest holdings make up 62% of its $7.43B portfolio in Q3 2021.
- Cresset Asset Management opened 145 new positions and closed 58 in Q3 2021.
- Cresset Asset Management's portfolio value rose 5.3% quarter-over-quarter to $7.43B.
Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.